PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns
Departments of 1 Molecular Physiology and Biological Physics, 2 Biomedical Engineering, and 3 Cardiovascular Medicine and 4 Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia; 5 Ludwig Institute for Cancer Research, Stockholm Branch, Stockholm, Sweden;...
Saved in:
Published in | American journal of physiology. Heart and circulatory physiology Vol. 296; no. 2; pp. H442 - H452 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.02.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Departments of 1 Molecular Physiology and Biological Physics, 2 Biomedical Engineering, and 3 Cardiovascular Medicine and 4 Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia; 5 Ludwig Institute for Cancer Research, Stockholm Branch, Stockholm, Sweden; 6 Department of Hematology/Oncology, ZymoGenetics, Seattle, Washington; and 7 Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece
Submitted 16 February 2008
; accepted in final form 20 November 2008
Platelet-derived growth factor (PDGF)-BB is a well-known smooth muscle (SM) cell (SMC) phenotypic modulator that signals by binding to PDGF -, β-, and ββ-membrane receptors. PDGF-DD is a recently identified PDGF family member, and its role in SMC phenotypic modulation is unknown. Here we demonstrate that PDGF-DD inhibited expression of multiple SMC genes, including SM -actin and SM myosin heavy chain, and upregulated expression of the potent SMC differentiation repressor gene Kruppel-like factor-4 at the mRNA and protein levels. On the basis of the results of promoter-reporter assays, changes in SMC gene expression were mediated, at least in part, at the level of transcription. Attenuation of the SMC phenotypic modulatory activity of PDGF-DD by pharmacological inhibitors of ERK phosphorylation and by a small interfering RNA to Kruppel-like factor-4 highlight the role of these two pathways in this process. PDGF-DD failed to repress SM -actin and SM myosin heavy chain in mouse SMCs lacking a functional PDGF β-receptor. Importantly, PDGF-DD expression was increased in neointimal lesions in the aortic arch region of apolipoprotein C-deficient (ApoE –/– ) mice. Furthermore, human endothelial cells exposed to an atherosclerosis-prone flow pattern, as in vascular regions susceptible to the development of atherosclerosis, exhibited a significant increase in PDGF-DD expression. These findings demonstrate a novel activity for PDGF-DD in SMC biology and highlight the potential contribution of this molecule to SMC phenotypic modulation in the setting of disturbed blood flow.
shear stress; disturbed blood flow; smooth muscle myosin heavy chain; smooth muscle -actin
Address for reprint requests and other correspondence: G. K. Owens, Dept. of Molecular Physiology and Biological Physics, Univ. of Virginia, MR5 Rm. 1220, 415 Lane Rd., PO Box 801394, Charlottesville, VA 22908 (e-mail: gko{at}virginia.edu ) |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Address for reprint requests and other correspondence: G. K. Owens, Dept. of Molecular Physiology and Biological Physics, Univ. of Virginia, MR5 Rm. 1220, 415 Lane Rd., PO Box 801394, Charlottesville, VA 22908 (e-mail: gko@virginia.edu) The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. |
ISSN: | 0363-6135 1522-1539 |
DOI: | 10.1152/ajpheart.00165.2008 |